Generative search prioritizes factual grounding over regional intent, making retrieval-aware content strategy critical for ...

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions The latest update is out from Genprex ( (GNPX) ). On January 6, 2026, Genprex reported positive preliminary ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Marvell (MRVL) gets a Buy: undervalued AI data center play with custom networking growth, plus key risks (China, capex, ...

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

EADaily, . After the high-profile political events, 2025 was supposed to be a calmer and somewhat transitional year for ...

Visa Inc. V, a global leader in payment processing, continues to deliver what long-term investors value most: consistency.

Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.

The 2025 US National Security Strategy shifts the United States decisively away from expansive regional engagement in the South Caucasus, instead favoring selective, interest-driven involvement.

Russia’s manipulation of history has evolved from symbolic memory politics into a deliberate instrument of state power aimed ...

When the first wave of students arrives on campus each fall, college safety and student affairs professionals brace for what has historically been the most vulnerable period for alcohol-related ...